BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21139680)

  • 1. Lack of association of CFD polymorphisms with advanced age-related macular degeneration.
    Zeng J; Chen Y; Tong Z; Zhou X; Zhao C; Wang K; Hughes G; Kasuga D; Bedell M; Lee C; Ferreyra H; Kozak I; Haw W; Guan J; Shaw R; Stevenson W; Weishaar PD; Nelson MH; Tang L; Zhang K
    Mol Vis; 2010 Nov; 16():2273-8. PubMed ID: 21139680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement factor D in age-related macular degeneration.
    Stanton CM; Yates JR; den Hollander AI; Seddon JM; Swaroop A; Stambolian D; Fauser S; Hoyng C; Yu Y; Atsuhiro K; Branham K; Othman M; Chen W; Kortvely E; Chalmers K; Hayward C; Moore AT; Dhillon B; Ueffing M; Wright AF
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8828-34. PubMed ID: 22003108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the common genetic associations of age-related macular degeneration upon systemic complement component C3d levels.
    Ristau T; Paun C; Ersoy L; Hahn M; Lechanteur Y; Hoyng C; de Jong EK; Daha MR; Kirchhof B; den Hollander AI; Fauser S
    PLoS One; 2014; 9(3):e93459. PubMed ID: 24675670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes.
    Reynolds R; Hartnett ME; Atkinson JP; Giclas PC; Rosner B; Seddon JM
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5818-27. PubMed ID: 19661236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common variation in the SERPING1 gene is not associated with age-related macular degeneration in two independent groups of subjects.
    Park KH; Ryu E; Tosakulwong N; Wu Y; Edwards AO
    Mol Vis; 2009; 15():200-7. PubMed ID: 19169411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss.
    Francis PJ; Hamon SC; Ott J; Weleber RG; Klein ML
    J Med Genet; 2009 May; 46(5):300-7. PubMed ID: 19015224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common complement C3 variant is associated with protection against wet age-related macular degeneration in a Japanese population.
    Yanagisawa S; Kondo N; Miki A; Matsumiya W; Kusuhara S; Tsukahara Y; Honda S; Negi A
    PLoS One; 2011; 6(12):e28847. PubMed ID: 22174912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of polymorphisms in C2, CFB and C3 with exudative age-related macular degeneration in a Korean population.
    Kim SJ; Lee SJ; Kim NR; Chin HS
    Exp Eye Res; 2012 Mar; 96(1):42-7. PubMed ID: 22273503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of C2/CFB variants in age-related macular degeneration and polypoidal choroidal vasculopathy in a Japanese population.
    Nakata I; Yamashiro K; Yamada R; Gotoh N; Nakanishi H; Hayashi H; Akagi-Kurashige Y; Tsujikawa A; Otani A; Saito M; Iida T; Oishi A; Matsuo K; Tajima K; Matsuda F; Yoshimura N
    Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):794-8. PubMed ID: 22232432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration.
    Smailhodzic D; Klaver CC; Klevering BJ; Boon CJ; Groenewoud JM; Kirchhof B; Daha MR; den Hollander AI; Hoyng CB
    Ophthalmology; 2012 Feb; 119(2):339-46. PubMed ID: 22133792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the alternative complement pathway in vitreous is controlled by genetics in age-related macular degeneration.
    Loyet KM; Deforge LE; Katschke KJ; Diehl L; Graham RR; Pao L; Sturgeon L; Lewin-Koh SC; Hollyfield JG; van Lookeren Campagne M
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6628-37. PubMed ID: 22930722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in complement regulators and susceptibility to age-related macular degeneration.
    Cipriani V; Matharu BK; Khan JC; Shahid H; Stanton CM; Hayward C; Wright AF; Bunce C; Clayton DG; Moore AT; Yates JR
    Immunobiology; 2012 Feb; 217(2):158-61. PubMed ID: 22024702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of complement proteins from the alternative pathway in patients with age-related macular degeneration are independent of Complement Factor H Tyr⁴⁰²His polymorphism.
    Silva AS; Teixeira AG; Bavia L; Lin F; Velletri R; Belfort R; Isaac L
    Mol Vis; 2012; 18():2288-99. PubMed ID: 22969267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration.
    Spencer KL; Hauser MA; Olson LM; Schmidt S; Scott WK; Gallins P; Agarwal A; Postel EA; Pericak-Vance MA; Haines JL
    Hum Mol Genet; 2007 Aug; 16(16):1986-92. PubMed ID: 17576744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement factor H and LOC387715 gene polymorphisms in a Greek population with age-related macular degeneration.
    Marioli DI; Pharmakakis N; Deli A; Havvas I; Zarkadis IK
    Graefes Arch Clin Exp Ophthalmol; 2009 Nov; 247(11):1547-53. PubMed ID: 19568762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Joint association of complement component 3 and CC-cytokine ligand2 (CCL2) or complement component 3 and CFH polymorphisms in age-related macular degeneration.
    Bonyadi M; Jabbarpoor Bonyadi MH; Yaseri M; Mohammadian T; Fotouhi N; Javadzadeh A; Soheilian M
    Ophthalmic Genet; 2017; 38(4):365-370. PubMed ID: 28095095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The involvement of complement factor B and complement component C2 in an Indian cohort with age-related macular degeneration.
    Kaur I; Katta S; Reddy RK; Narayanan R; Mathai A; Majji AB; Chakrabarti S
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):59-63. PubMed ID: 19696172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk.
    Rivera A; Fisher SA; Fritsche LG; Keilhauer CN; Lichtner P; Meitinger T; Weber BH
    Hum Mol Genet; 2005 Nov; 14(21):3227-36. PubMed ID: 16174643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR Manipulation of Age-Related Macular Degeneration Haplotypes in the Complement System: Potential Future Therapeutic Applications/Avenues.
    Salman A; McClements ME; MacLaren RE
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in five genes and the severity of age-related macular degeneration: results from the Muenster aging and retina study.
    Farwick A; Dasch B; Weber BH; Pauleikhoff D; Stoll M; Hense HW
    Eye (Lond); 2009 Dec; 23(12):2238-44. PubMed ID: 19169232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.